Yogurt and Hot Dogs Are Both "Ultra-Processed" — So Why Are Governments Making Laws Before Anyone Can Define the Term?

Here's where things get genuinely consequential — and where I think the story gets most underreported. The UPF regulatory debate isn't just a public health question. Over the next five years, it is shaping up to be a mega-issue that reshapes global food industry economics, litigation landscapes, and international health equity simultaneously. Let me break this down by timeframe, because the near-term and long-term dynamics are quite different from each other.

In the near term — roughly late 2026 through the first half of 2027 — the most dramatic regulatory movement is likely to come from the United States. The FDA's formal Request for Information on UPF definitions, launched in July 2025, should yield results before the end of 2026. My read, however, is that those results will land as a "recommendation" or "interim guidance" rather than a binding statutory definition. The reason is straightforward: the moment a unified definition is officially codified, thousands of food companies gain clear standing to sue. So expect the FDA to pursue an ingredient-by-ingredient approach instead — banning specific substances like potassium bromate or synthetic dyes one at a time, rather than adopting NOVA wholesale. Arizona's healthy schools law already demonstrated this targeted model. The single biggest legal event to watch for: when a major food company files a constitutional challenge to California's Real Food Healthy Kids Act. My prediction is that this happens before the end of 2027.

Beginning with the 2026-27 school year, 11 specific additives will be banned from school foods in Arizona — another signal that the "targeted ingredient" regulatory model will precede any comprehensive UPF definition at the federal level. Simultaneously, California's implementation machinery will accelerate, creating visible reference points that other states will use to justify similar bills. I expect five to eight states to pass some version of school UPF legislation by mid-2027. New York, Illinois, and Washington are the most probable early adopters given their political environments and prior food policy records. The cascade is structurally predictable: once California's framework is operational and generating data, the political resistance in progressive-leaning states drops significantly.

Brazil's 2026 school year is the first to operate under the 10% UPF cap — the culmination of a six-year stepped restriction policy — and the first comprehensive effectiveness data will begin emerging by early 2027. If results are positive, the Brazilian model will spread rapidly through Latin America and Southeast Asia. If the data is mixed, UPF regulation opponents will weaponize it as proof that the whole framework is misguided. Colombia's 20% UPF tax data will also crystallize around this time: the earlier 10% rate produced a 5% sales decline, so a 20% rate could realistically push that to 10-15%. These Latin American empirical datasets will become the primary reference evidence for any country weighing UPF taxation going forward. The first truly independent, government-level evaluation of UPF school policy will carry outsized influence on the global debate.

In the mid-term — 2027 through 2028 — the game starts to change more fundamentally. The single largest variable is the final publication of the U.S. 2025-2030 Dietary Guidelines and the downstream policy cascade they trigger. Because this is the first dietary guidelines cycle to explicitly include UPF-related research questions, the conclusions could drive cascading changes across school lunch nutrition standards, WIC and SNAP eligible food lists, military meal programs, and hospital dietary guidelines in one coordinated wave. That is the first domino. The second is large-scale industry restructuring: just as the UK's sugar levy induced voluntary manufacturer reformulation, a federal dietary guidelines shift could make "reformulation is cheaper than litigation" the dominant corporate calculation. Expect significant "UPF-free" and "clean label" product launches from major food companies in the 2027-2028 window as they reposition ahead of anticipated standards.

The core mid-term risk, however, is that the regulatory landscape becomes dominated by litigation rather than legislation. I expect at least one major food industry organization to file a constitutional challenge against either California's law or any federal UPF guidance, arguing that NOVA-based classification represents arbitrary government action without settled scientific support. The Consumer Brands Association has already developed this legal argument publicly, and the popcorn classification inconsistency — where two nearly identical products receive different regulatory designations based on a single ingredient — is the kind of concrete, relatable example that plays well before judges and juries alike. If a court issues an early high-profile ruling siding with the food industry, the entire regulatory framework gets destabilized and pushed back by two to three years. This is the central trigger for the bear scenario I'll describe below, and it is more realistic than most public health advocates want to acknowledge.

For the long term — 2028 through 2031 — I see three distinct possible worlds. In the optimistic scenario, which I assign roughly 25% probability, science delivers a second-generation classification framework that supersedes NOVA by combining nutritional profiling with processing-level data to produce a genuinely objective, quantifiable standard. WHO builds an international consensus around this framework, the food industry in advanced economies completes large-scale reformulation, and a coordinated global tax-and-incentive structure emerges. By 2030, UPF's share of average daily caloric intake in developed countries falls from the current 50%+ range to somewhere around 35-40%. For this scenario to materialize, two conditions are necessary: bipartisan political durability in the United States, and the food industry choosing reformulation over endless litigation as its primary strategic response.

The base case — which I put at 50% probability, making it the most likely single path — is what I would describe as regulatory fragmentation locking in permanently. The United States ends up with no unified federal standard, just a growing and increasingly contradictory patchwork of state-by-state rules. The EU develops its own separate framework. Latin America broadly follows Brazil's model. Asia remains largely unregulated. Large food corporations run separate product lines for different regulatory jurisdictions, generating significant compliance overhead without actually improving population health at scale. Global UPF consumption declines only marginally — perhaps 5-10% in developed countries by 2030 — while the fundamental food environment for low-income populations remains essentially unchanged. This is the path of least regulatory resistance and, unfortunately, the most probable destination if current political dynamics hold.

In the bear case — 25% probability, but with signals running stronger than I'd like — a federal court delivers a major ruling against NOVA-based regulation, establishing a precedent that NOVA-derived food policy is constitutionally arbitrary. The MAHA movement's credibility collapses under its own contradictions. CDC budget cuts eliminate the enforcement and monitoring infrastructure. SNAP and WIC reductions deepen food insecurity, paradoxically increasing UPF consumption among the most vulnerable. And — this is the global dimension that almost nobody in the mainstream policy conversation is discussing — UPF products pushed out of heavily regulated developed markets get redirected as exports toward lower-income countries with weaker or nonexistent food regulations. This "UPF dumping" effect could prove to be the most consequential long-term driver of global health inequality to emerge from this entire regulatory wave.

The tobacco comparison people reach for is instructive but imperfect in ways that matter. Tobacco had two structural advantages that UPF regulation lacks: an unambiguous scientific consensus that any amount causes harm, and a clear set of substitutable alternatives. The UPF case is much messier — "certain types of processing harm certain people under certain conditions" is a harder legal and political argument to make stick. Tobacco regulation also ultimately succeeded because internal industry documents revealed deliberate suppression of known harm evidence. Whether the food industry has equivalent suppressed evidence remains an open and consequential question. Tobacco's market size was also far smaller than today's $1.9 trillion UPF industry. These structural differences collectively push the UPF regulatory trajectory toward the alcohol policy model — progressive taxes, advertising restrictions, labeling requirements, age-limited marketing — rather than anything approaching the near-prohibition trajectory that tobacco eventually faced.

The cascade effects of serious UPF regulation deserve careful attention. First-order effect: compliance costs for food manufacturers translate directly into higher retail prices for consumers — including those who can least afford price increases. Second-order effect: large food corporations have the capital to reformulate and absorb compliance costs; small and mid-sized food companies typically don't, accelerating industry consolidation and reducing the product diversity that currently helps keep certain categories affordable. Third-order effect: in markets where UPF regulation is strict, manufacturers face growing incentives to redirect product lines toward export markets with weaker regulations — meaning the populations already bearing the greatest burden of UPF-linked disease may increasingly become those in the world's lower-income countries. This third-order effect is systematically underanalyzed in the current policy conversation, and I believe it will emerge as a major global health equity flash point within the next decade.

A few scenarios that could prove my forecast wrong deserve mention, because intellectual honesty requires acknowledging them. If a genuine scientific breakthrough produces an objective, quantitative UPF classification framework within the next two to three years, litigation risk drops dramatically and the regulatory timeline could accelerate significantly beyond my base case. If AI-enabled personalized nutrition reaches mass-market scale — enabling individuals to understand how specific foods interact with their unique metabolic and genetic profiles — the rationale for categorical one-size-fits-all regulation may erode naturally, replaced by something more precise and individually relevant. And if innovative food access infrastructure — mobile fresh food markets, neighborhood-scale vertical farms, community-owned food co-ops — achieves mass adoption in food-desert communities, UPF dependency could decline organically without top-down regulation being the primary lever. For readers navigating this space personally: resist the reflex of treating "ultra-processed" as a universal condemnation and learn to read nutritional profiles instead. When politicians invoke "health," always ask specifically who benefits from the proposed regulation and who bears its costs. Local engagement with food access infrastructure improvements will generate faster, more concrete results than waiting for national regulatory frameworks to reach coherent agreement.